Skip to main content
logo
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
28.25
+1.80 (6.81%)
Jul 30, 2026, 4:00 PM EDT - Market closed

Arcus Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
236247258117112383
Revenue Growth
67.38%-4.26%120.51%4.46%-70.76%391.03%
Gross Profit
236247258117112383
Operating Income
-398-386-330-340-28054
Net Income
-369-353-283-307-26753
Earnings Per Share
-3.23-3.29-3.14-4.15-3.710.71
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
8229819787591,009499
Total Debt
1009948000
Net Cash (Debt)
7228829307591,009499
Net Cash Growth
-23.92%-5.16%22.53%-24.78%102.20%-30.05%
Net Cash Per Share
6.328.2110.3210.2614.016.74

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-488-482-170-306438-256
Capital Expenditures
-1-2-6-24-6-26
Free Cash Flow
-489-484-176-330432-282
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-168.64%-156.28%-127.91%-290.60%-250.00%14.10%
Pretax Margin
-156.36%-142.91%-109.30%-257.26%-237.50%14.36%
Profit Margin
-156.36%-142.91%-109.69%-262.39%-238.39%13.84%
FCF Margin
-207.20%-195.95%-68.22%-282.05%385.71%-73.63%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----57.00
Forward PE
-13.1113.1113.1113.1113.11
P/FCF Ratio
----3.49-
PS Ratio
15.0612.095.3212.3313.467.48